232 related articles for article (PubMed ID: 10395026)
21. P2X(1)-mediated activation of extracellular signal-regulated kinase 2 contributes to platelet secretion and aggregation induced by collagen.
Oury C; Toth-Zsamboki E; Vermylen J; Hoylaerts MF
Blood; 2002 Oct; 100(7):2499-505. PubMed ID: 12239162
[TBL] [Abstract][Full Text] [Related]
22. Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2cyc receptors.
Baurand A; Eckly A; Bari N; Léon C; Hechler B; Cazenave JP; Gachet C
Thromb Haemost; 2000 Sep; 84(3):484-91. PubMed ID: 11019976
[TBL] [Abstract][Full Text] [Related]
23. Both the ADP receptors P2Y1 and P2Y12, play a role in controlling shape change in human platelets.
Jagroop IA; Burnstock G; Mikhailidis DP
Platelets; 2003 Feb; 14(1):15-20. PubMed ID: 12623443
[TBL] [Abstract][Full Text] [Related]
24. Cardiomyogenesis of embryonic stem cells upon purinergic receptor activation by ADP and ATP.
Mazrouei S; Sharifpanah F; Bekhite MM; Figulla HR; Sauer H; Wartenberg M
Purinergic Signal; 2015 Dec; 11(4):491-506. PubMed ID: 26395809
[TBL] [Abstract][Full Text] [Related]
25. Plasma ectonucleotidases prevent desensitization of purinergic receptors in stored platelets: importance for platelet activity during thrombus formation.
Cauwenberghs S; Feijge MA; Hageman G; Hoylaerts M; Akkerman JW; Curvers J; Heemskerk JW
Transfusion; 2006 Jun; 46(6):1018-28. PubMed ID: 16734820
[TBL] [Abstract][Full Text] [Related]
26. Effects of analogues of adenine nucleotides on increases in intracellular calcium mediated by P2T-purinoceptors on human blood platelets.
Hall DA; Hourani SM
Br J Pharmacol; 1993 Mar; 108(3):728-33. PubMed ID: 8467360
[TBL] [Abstract][Full Text] [Related]
27. Nucleoside triphosphates inhibit ADP, collagen, and epinephrine-induced platelet aggregation: role of P2Y₁ and P2Y₁₂ receptors.
Aslam M; Sedding D; Koshty A; Santoso S; Schulz R; Hamm C; Gündüz D
Thromb Res; 2013 Nov; 132(5):548-57. PubMed ID: 24071464
[TBL] [Abstract][Full Text] [Related]
28. The P2 receptors and congenital platelet function defects.
Cattaneo M
Semin Thromb Hemost; 2005 Apr; 31(2):168-73. PubMed ID: 15852220
[TBL] [Abstract][Full Text] [Related]
29. The role of ADP receptors in platelet function.
Murugappa S; Kunapuli SP
Front Biosci; 2006 May; 11():1977-86. PubMed ID: 16368572
[TBL] [Abstract][Full Text] [Related]
30. ATP stimulates Ca2+ mobilization by a nucleotide receptor in glomerular endothelial cells.
Briner VA; Kern F
Am J Physiol; 1994 Feb; 266(2 Pt 2):F210-7. PubMed ID: 8141322
[TBL] [Abstract][Full Text] [Related]
31. Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y1 receptor in vitro.
Maayani S; Schwarz TE; Patel ND; Craddock-Royal BD; Tagliente TM
Platelets; 2003; 14(7-8):445-62. PubMed ID: 14713514
[TBL] [Abstract][Full Text] [Related]
32. Ligand specificity and ticlopidine effects distinguish three human platelet ADP receptors.
Geiger J; Hönig-Liedl P; Schanzenbächer P; Walter U
Eur J Pharmacol; 1998 Jun; 351(2):235-46. PubMed ID: 9687008
[TBL] [Abstract][Full Text] [Related]
33. Ca2+ responses to ATP via purinoceptors in the early embryonic chick retina.
Sugioka M; Fukuda Y; Yamashita M
J Physiol; 1996 Jun; 493 ( Pt 3)(Pt 3):855-63. PubMed ID: 8799905
[TBL] [Abstract][Full Text] [Related]
34. Identification, characterization, and inhibition of the platelet ADP receptors.
Gachet C
Int J Hematol; 2001 Dec; 74(4):375-81. PubMed ID: 11794691
[TBL] [Abstract][Full Text] [Related]
35. Presence of P2X1 purinoceptors in human platelets and megakaryoblastic cell lines.
Vial C; Hechler B; Léon C; Cazenave JP; Gachet C
Thromb Haemost; 1997 Dec; 78(6):1500-4. PubMed ID: 9423802
[TBL] [Abstract][Full Text] [Related]
36. ATP modulates intracellular Ca2+ and firing rate through a P2Y1 purinoceptor in cane toad pacemaker cells.
Ju YK; Huang W; Jiang L; Barden JA; Allen DG
J Physiol; 2003 Nov; 552(Pt 3):777-87. PubMed ID: 12949218
[TBL] [Abstract][Full Text] [Related]
37. FPL 66096: a novel, highly potent and selective antagonist at human platelet P2T-purinoceptors.
Humphries RG; Tomlinson W; Ingall AH; Cage PA; Leff P
Br J Pharmacol; 1994 Nov; 113(3):1057-63. PubMed ID: 7858849
[TBL] [Abstract][Full Text] [Related]
38. The P2Y1 receptor, necessary but not sufficient to support full ADP-induced platelet aggregation, is not the target of the drug clopidogrel.
Hechler B; Eckly A; Ohlmann P; Cazenave JP; Gachet C
Br J Haematol; 1998 Dec; 103(3):858-66. PubMed ID: 9858246
[TBL] [Abstract][Full Text] [Related]
39. Functional evidence that ATP or a related purine is an inhibitory NANC neurotransmitter in the mouse jejunum: study on the identity of P2X and P2Y purinoceptors involved.
De Man JG; De Winter BY; Seerden TC; De Schepper HU; Herman AG; Pelckmans PA
Br J Pharmacol; 2003 Nov; 140(6):1108-16. PubMed ID: 14530212
[TBL] [Abstract][Full Text] [Related]
40. P2X1 stimulation promotes thrombin receptor-mediated platelet aggregation.
Erhardt JA; Toomey JR; Douglas SA; Johns DG
J Thromb Haemost; 2006 Apr; 4(4):882-90. PubMed ID: 16634759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
